Inari Medical Inc. Investor Alert: Class Action Lawsuit

Investors can contact law firm free to learn more about loss recovery

LOS ANGELES, July 9, 2024 (GLOBE NEWSWIRE) — Portnoy Law Firm advises Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI) announced today that a shareholder has filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Inari Medical securities between February 23, 2022 and February 28, 2024.

Investors who have suffered losses on their investment are asked to contact Lesley Portnoy, Esq.

Investors are encouraged to contact attorney Lesley F. Portnoy by phone at 310-682-9993 or email at [email protected] to discuss their legal rights, or click here to join a case at The Portnoy Law Firm can provide a free case evaluation and discuss investors’ options for pursuing a claim to recover their losses.

The complaint alleges that throughout the Period of the Complaint, Inari Medical failed to disclose to investors that: (i) the Company defrauded investors, including plaintiff; (ii) caused the market price of Inari common stock to exceed its true value; and (iii) caused plaintiff, as well as other class members, to purchase or otherwise acquire shares of Inari common stock at artificially inflated prices that did not reflect the true value of the stock during the Period of the Complaint. In furtherance of their unlawful plan, scheme, or course of conduct, defendants engaged in the conduct alleged herein.

Please visit our website for more information and to submit your transaction details.

Portnoy Law Firm represents investors in pursuing claims for corporate misconduct. Founding partner has recovered more than $5.5 billion for injured investors. Attorney Advertising. Previous results do not guarantee similar results.

Lesley F. Portnoy, Attorney at Law
Admitted to the bar in California and New York
[email protected]
Attorney Advertising